新闻

Lonza: NextPharma Set To Acquire 2 Lonza Sites Specialized In Lipid Oral Dosage Forms.

19 Jan 2021 14:03

Agreement initiates process for future acquisition of Lonza sites in Ploermel (FR) and Edinburgh (UK) allowing NextPharma to broaden technology offering into lipid finished dosage forms. Centers of excellence employing a total of 390 staff offer expertise in Lipid Oral Dosage Forms including softgels and liquid-filled hard capsules for the pharma and nutrition markets. Sustainable growth and people development a priority for both companies...

Attachments:

Source: ShareInvestor Express